18 reports

Aerie Pharmaceuticals.

  • Eye Disease
  • Health Services
  • Ophthalmology
  • Pharmaceutical
  • RXi Pharmaceuticals Corporation
  • OPHTHALMOLOGY THERAPEUTICS MARKET, FIRST-IN-CLASS PRODUCTS IN PIPELINE (PART 1), 2016
  • OPHTHALMOLOGY THERAPEUTICS MARKET, FIRST-IN-CLASS THERAPIES NOT INVOLVED IN PREVIOUS DEALS (PART 1), 2016

FIGURE ##: PHARMACEUTICAL INDUSTRY, GLOBAL, LICENSING DEAL VALUES BY STAGE OF DEVELOPMENT ($M), 2006-2014 Overall, first-in-class drugs seem to be the most attractive licensing prospect across the pharmaceutical industry.

  • Eye Disease
  • Health Services
  • Ophthalmology
  • Pharmaceutical
  • RXi Pharmaceuticals Corporation

MOBILE Mobile advertising has primarily driven social media ad spend by pharmaceutical & healthcare brands, accounting for ##%, in 2015.

  • Advertising
  • Computer
  • Pharmaceutical
  • Web 2.0
  • Tencent Holdings Ltd

FIGURE ##: CHINA RETAIL BRANDS' ONLINE ADVERTISING SPEND - SPLIT BY MOBILE AND DESKTOP (US$ MILLION), 2015 VS. 2020 ##. ## Pharmaceutical & Healthcare Online Ad Spend Being among the few countries that allow direct to consumer marketing of pharmaceutical products, digital ad

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd

MOBILE Mobile advertising has primarily driven social media ad spend by pharmaceutical & healthcare brands, accounting for ##%, in 2014.

  • Advertising
  • Marketing
  • Pharmaceutical
  • Web 2.0
  • Tencent Holdings Ltd

FIGURE ##: CHINA PHARMACEUTICAL & HEALTHCARE BRANDS' ONLINE ADVERTISING SPEND (US$ MILLION), 2010-2019 ##. ##. ## SNAPSHOT, 2010-2019 FIGURE ##: CHINA PHARMACEUTICAL & HEALTHCARE BRANDS' ONLINE ADVERTISING SPEND - BREAKDOWN BY MARKETING OBJECTIVE (%), 2014VS. 2019 Bran

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd
  • RXI PHARMACEUTICALS CORP, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS
  • RXI PHARMACEUTICALS CORP, SUBSIDIARIES
  • Pharmaceutical
  • United States
  • Company
  • Company Operations
  • RXi Pharmaceuticals Corporation
  • PROMORE PHARMA
  • RXI PHARMACEUTICALS CORP
  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • RXi Pharmaceuticals Corporation
  • PROMORE PHARMA
  • RXI PHARMACEUTICALS CORP
  • Dermatology
  • Hospital
  • Pharmaceutical
  • Therapy
  • RXi Pharmaceuticals Corporation
  • RXI PHARMACEUTICALS CORP
  • KELOIDS - PIPELINE BY RXI PHARMACEUTICALS CORP, H2 2016
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • RXi Pharmaceuticals Corporation
  • RXI PHARMACEUTICALS CORP
  • PROLIFERATIVE VITREORETINOPATHY (PVR) - PIPELINE BY RXI PHARMACEUTICALS CORP, H1 2017
  • Pharmaceutical
  • United States
  • Litigation And Patent
  • Product Initiative
  • RXi Pharmaceuticals Corporation
  • PARTNER 2: CYTRX CORPORATION
  • PARTNERSHIP - DEAL REPORTS
  • Healthcare
  • Pharmaceutical
  • United States
  • Company
  • RXi Pharmaceuticals Corporation
  • VALUATION MULTIPLES (RXI PHARMACEUTICALS CORPORATION)
  • VALUATION MULTIPLES (RXI PHARMACEUTICALS CORPORATION)
  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Corporate Finance
  • RXi Pharmaceuticals Corporation
  • RXI PHARMACEUTICALS CORP
  • KELOIDS - PIPELINE BY RXI PHARMACEUTICALS CORP, H1 2017
  • Pharmaceutical
  • Therapy
  • World
  • Product Initiative
  • RXi Pharmaceuticals Corporation
  • RXI PHARMACEUTICALS CORPORATION
  • PIPELINE BY RXI PHARMACEUTICALS CORPORATION, H1 2016
  • Cell Therapy
  • Pharmaceutical
  • Therapy
  • Product Initiative
  • RXi Pharmaceuticals Corporation
  • RXI PHARMACEUTICALS CORPORATION SNAPSHOT
  • RXI PHARMACEUTICALS CORPORATION - RESEARCH AND DEVELOPMENT OVERVIEW
  • Pharmaceutical
  • R&D
  • Research And Development
  • Therapy
  • RXi Pharmaceuticals Corporation
  • HYPERTROPHIC SCARS - PIPELINE BY RXI PHARMACEUTICALS CORPORATION, H2 2015
  • PRODUCTS UNDER DEVELOPMENT BY COMPANIES, H2 2015
  • Pharmaceutical
  • Research And Development
  • Therapy
  • United States
  • RXi Pharmaceuticals Corporation
  • HYPERTROPHIC SCARS - PIPELINE BY RXI PHARMACEUTICALS CORPORATION, H1 2015
  • Hypertrophic Scars - Recent Pipeline Updates
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative
  • RXi Pharmaceuticals Corporation